nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active surveillance vs radical prostatectomy
|
Abrahamsson, Per-Anders |
|
2007 |
100 |
s2 |
p. 26-28 |
artikel |
2 |
Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer
|
Bolla, Michel |
|
2007 |
100 |
s2 |
p. 44-47 |
artikel |
3 |
Adjuvant treatment to surgery
|
Boccon-Gibod, Laurent |
|
2007 |
100 |
s2 |
p. 40-43 |
artikel |
4 |
Chemoprevention of prostate cancer: lessons learned
|
Thompson, Ian M. |
|
2007 |
100 |
s2 |
p. 15-17 |
artikel |
5 |
Chemotherapy of premalignant lesions: new insights
|
Ravery, Vincent |
|
2007 |
100 |
s2 |
p. 18-21 |
artikel |
6 |
Combination of somatostatin analogues and dexamethasone (antisurvival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis
|
Koutsilieris, Michael |
|
2007 |
100 |
s2 |
p. 60-62 |
artikel |
7 |
Controversies regarding screening for prostate cancer
|
Crawford, E. David |
|
2007 |
100 |
s2 |
p. 5-7 |
artikel |
8 |
Current prostate cancer: 20 years later
|
Marberger, Michael |
|
2007 |
100 |
s2 |
p. 11-14 |
artikel |
9 |
Definition and management of prostate-specific antigen recurrence after local therapy
|
Martínez-Piñeiro, Luis |
|
2007 |
100 |
s2 |
p. 32-35 |
artikel |
10 |
Editorial
|
Djavan, Bob |
|
2007 |
100 |
s2 |
p. 1 |
artikel |
11 |
European Study of Radical Prostatectomy: time trends in Europe, 1993–2005
|
Djavan, Bob |
|
2007 |
100 |
s2 |
p. 22-25 |
artikel |
12 |
Hormone-refractory prostate cancer: what have we learned?
|
Wirth, Manfred P. |
|
2007 |
100 |
s2 |
p. 56-59 |
artikel |
13 |
How to preserve potency and continence in localized prostate cancer
|
Breda, Guglielmo |
|
2007 |
100 |
s2 |
p. 29-31 |
artikel |
14 |
Is hormone ablation still the right choice for advanced prostate cancer?
|
Fitzpatrick, John M. |
|
2007 |
100 |
s2 |
p. 36-39 |
artikel |
15 |
Is the era of prostate-specific antigen over?
|
Djavan, Bob |
|
2007 |
100 |
s2 |
p. 8-10 |
artikel |
16 |
Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer: state of the art
|
Schally, Andrew V. |
|
2007 |
100 |
s2 |
p. 2-4 |
artikel |
17 |
Molecular aspects of hormone-independent prostate cancer
|
Schalken, Jack A. |
|
2007 |
100 |
s2 |
p. 52-55 |
artikel |
18 |
Multiple intracrine hormonal targets in the prostate: opportunities and challenges
|
Labrie, Fernand |
|
2007 |
100 |
s2 |
p. 48-51 |
artikel |